Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for COVID-19 in Hospitalized Men
NCT04365127Phase 1Completed
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of progesterone in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoint: Change in clinical status of subjects at Day 7 based on a 7-point ordinal scale. Started Apr 2020; status: completed.
02
Drugs
progesterone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04365127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04365127.